The Patent Finder

Sanofi-Synthelabo

Also on record
Records under this name other than patents Sanofi-Synthelabo holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Sanofi-Synthelabo

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,524,857Pharmaceutical Combinations Based on Pyridoindolone Derivatives and Anticancer Agents
Formerly held
Term ended
Ended no later than Oct 26, 2024 · Medium confidence
Term endedEnded no later than Oct 26, 2024Medium confidence
US 7,462,725Chloromethylation of Thiophene
Formerly held
Term ended
Term ended Sep 29, 2024 · High confidence
Term endedTerm ended Sep 29, 2024High confidence
US 7,235,5543-Heteroarly-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b] INDOLE-1-Acetamide Derivatives, Preparation and Use Thereof in Medicaments
Formerly held
Term ended
Term ended Feb 24, 2024 · High confidence
Term endedTerm ended Feb 24, 2024High confidence
US 7,288,659Acylaminothiazole Derivatives, Their Preparation and Therapeutic Use
Formerly held
Term ended
Term ended Jan 29, 2024 · High confidence
Term endedTerm ended Jan 29, 2024High confidence
US 7,223,750Derivatives of 5-(PYRIDIN-3-YL)-1-Azabicyclo[3.2.1] Octane, the Preparation Thereof and the Application of Same in Therapeutics
Formerly held
Term ended
Term ended Jul 10, 2023 · High confidence
Term endedTerm ended Jul 10, 2023High confidence
US 7,381,835Resolution Process for (R)-(-)-2-Hydroxy-2-(2-Chlorophenyl) Acetic Acid
Formerly held
Term ended
Term ended Jun 9, 2023 · High confidence
Term endedTerm ended Jun 9, 2023High confidence
US 7,157,454Derivatives of N-(ARYLSULFONYL)beta-Aminoacids Comprising a Substituted Aminomethyl Group, the Preparation Method Thereof and the Pharmaceutical Compositions Containing Same
Formerly held
Term ended
Term ended Apr 20, 2023 · High confidence
Term endedTerm ended Apr 20, 2023High confidence
US 7,928,073Purified Polypeptides Having IL-13 Receptor Activity
Formerly held
Lapsed on the fee record
Ended Apr 19, 2023 · High confidence
Lapsed on the fee recordEnded Apr 19, 2023High confidence
US 7,109,1943-Heteroaryl-3, 5-Dihydro-4-OXO-4H-PYRIDAZINO[4, 5-B]INDOLE-1-Carboxamide Derivatives Their Preparations and Therapeutic Use
Formerly held
Term ended
Term ended Mar 15, 2023 · High confidence
Term endedTerm ended Mar 15, 2023High confidence
US 7,094,223Device for Protecting a Syringe Needle
Formerly held
Term ended
Term ended Dec 24, 2022 · High confidence
Term endedTerm ended Dec 24, 2022High confidence
10 of 614 patents shown.
Pro members see all 614.
Pro members: see all 614 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited